Hospital Variation and Patient Characteristics Associated With Vena Cava Filter Utilization. Issue 1 (January 2017)

• Record Type: Journal Article
• Authors: Brown, Joshua D.; Talbert, Jeffery C.
• Is Part Of: Medical care. Volume 55:Issue 1(2017)
• Publication Date: 2017-01
• Subjects: vena cava filters -- deep vein thrombosis -- pulmonary embolism; Economics, Medical -- Periodicals; Insurance, Health -- Periodicals; Santé, Services de -- Administration -- Périodiques; Soins médicaux -- Périodiques; Medical economics -- Periodicals; Health insurance -- Periodicals; Medical economics -- United States -- Periodicals; Health insurance -- United States -- Periodicals; Comprehensive Health Care -- Periodicals; Personal Health Services -- Periodicals; Gezondheidszorg; Économie de la santé -- Périodiques; Santé, Services de -- Périodiques; Health insurance; Medical economics; United States; Periodicals; 362.10973
• DOI: 10.1097/MLR.0000000000000599
• Languages: English
• ISSNs: 0025-7079

Abstract

Abstract : Introduction: There is a wide variation in the use of vena cava filter (VCF). Objective: This study assessed the hospital and patient characteristics associated with VCF use in deep vein thrombosis (DVT) and pulmonary embolism (PE). Methods: Inpatient discharge data from all acute care hospitals with DVT/PE during 2008–2014 in Kentucky were used. Hierarchical logistic regression models were used to evaluate the relationships of study variables with VCF use. Results: During the study period, 81, 922 discharges for DVT/PE were observed and 10.5% of these received a VCF. This included 12, 083 cases of PE+DVT, 18, 571 cases of PE only, and 51, 268 cases of DVT only. VCF use among these groups was 22.7%, 6.0%, and 7.8%, respectively. In adjusted analyses, VCF use was associated with increasing age, indicating that those over age 65 were twice as likely to receive a filter compared with the reference (21–25 y old) group. Significant comorbidities associated with VCF use included cancer, liver disease, cerebrovascular disease, atrial fibrillation, anemia, and concurrent bleeding. Lower extremity, proximal DVTs, and patients receiving thrombolytic therapy or embolectomy, those having surgery, and those who were unstable or had trauma, were also more likely to receive a filter. Among cancer types, brain and metastatic tumors were significantly associated with VCF use. Between-hospital variation after controlling for all covariates was 7.1%. Conclusions: There was high variation in the use of VCFs. Several high-risk subgroups were more likely to use VCFs including older adults and those with cancer and concurrent bleeding. Abstract : Supplemental Digital Content is available in the text.